| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter serves as an EVP, Chief Commercial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 35 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Heerma Peter's trades have earned a middling insider score of 53/100 across 21 rated trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -26.6%.
The biggest single holding is TVTX (~$7.6M) as EVP, Chief Commercial Officer. The recent filings there lean toward selling, a net 359,908 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | EVP, Chief Commercial Officer | Sale+OE10b5-1 | 283,189 | $63.06 | $17,857,829.96 | -70.8% | - | - | |
| May 5, 2026 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sale+OE | 2,174 | $46.65 | $101,417.10 | -1.5% | +22.7% | - | |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 7,215 | $41.93 | $302,516.29 | -4.9% | +33.6% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 7,310 | $32.12 | $234,797.20 | -5.3% | +36.8% | - | |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell10b5-1 | 4,980 | $40.00 | $199,200.00 | -4.2% | -33.5% | - | |
| Oct 31, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell10b5-1 | 5,591 | $35.00 | $195,685.00 | -4.5% | -9.0% | - | |
| Oct 28, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell10b5-1 | 2,662 | $30.00 | $79,860.00 | -2.1% | +0.4% | +68.0% | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sale+OE | 1,771 | $21.05 | $37,279.55 | -1.4% | -25.5% | +109.2% | |
| Feb 12, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 5,642 | $24.33 | $137,275.55 | -4.3% | -9.7% | +31.9% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 5,166 | $20.12 | $103,939.92 | -4.0% | +5.9% | +62.4% |